2Ali F,Affan Q.Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized[J].Gastrointest Endosc,2003,57(3):435-440.
3Cotton P B,Lehman G,Vennes J A,et al.Endoscopic sphincterotomy comp lications and their management:an attempt at consensus[J].Gastrointest Endosc,1991,37(3):383-393.
4Freeman M L.Post-ERCP Pancreatitis:Patient and Technique-Related Risk Factors[J].JOP.J Pancreas (Online),2002,3(6):169-176.
5Curallini G,Frulloni I.Antiproteasic agent in the prevention of post-ERCP pancreatitis:rational for use and clinical results[J].TOP,2003,4:75-82.
7Niederau C,Pohlmann U,Lubke H,et al.Prophylactic antibotic treatment in therapeutic or complicated diagnostic ERCP:results of a randomized controlled clinical study [J].Gastrointest Endosc,1994,40:533-537.
8Loperfido S,Angelini G,Benedteei G,et al.Major early complications from diagnostic and therapeutic ERCP:a prospective multicenter study [J].Gastrointest Endosc,1998,48:1-10.
9Johnson GK,Geenen JE,Johanson JF,et al.Evaluation of post ERCP pancreatitis:potential causes woted during controlled study of differing contrast media.Midwest pancreatobiliary study group[J].Gastrointest Endosc,1997,46:217-222.
10Suzuki M,Kobayashi H,Tannaka Y,et al.Structure and function analysis of urinarytrypin inhibitor(UTI):identification of binding domains and signaling property of UTI by analysis of trunctated proteins [J].Biochim Biophys Acta,2001,1547:26-36.
